INSM: Insmed, Inc.
About
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
Current Value
$73.501 Year Return
Current Value
$73.501 Year Return
Key Details
Market Cap
$13.19B
P/E Ratio
-13.27
1Y Stock Return
202.50%
1Y Revenue Growth
22.13%
Dividend Yield
0.00%
Price to Book
27.3
Strategies that include INSM
Stock's related to INSM
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AGIO | 46.37% | $3.10B | +148.79% | 0.00% |
| ARCT | 41.66% | $489.20M | -21.27% | 0.00% |
| FWRD | 34.82% | $998.06M | -46.90% | 0.69% |
| CORT | 32.29% | $5.69B | +113.63% | 0.00% |
| SMLR | 31.51% | $336.72M | +25.48% | 0.00% |
| KIRK | 29.82% | $20.86M | -17.19% | 0.00% |
| SPCE | 29.66% | $196.64M | -84.01% | 0.00% |
| KRO | 26.96% | $1.30B | +35.66% | 5.51% |
| POAI | 26.45% | $4.29M | -78.60% | 0.00% |
| HUBS | 26.40% | $35.23B | +44.73% | 0.00% |
| ITRN | 25.30% | $569.91M | +10.76% | 5.16% |
| SUNS | 25.17% | $105.89M | +35.31% | 1.37% |
| FUN | 24.23% | $4.60B | -16.51% | 0.00% |
| ARLO | 24.11% | $1.20B | +31.21% | 0.00% |
| USM | 23.89% | $5.35B | +41.82% | 0.00% |
| CRNC | 23.85% | $124.16M | -82.36% | 0.00% |
| HIMS | 23.42% | $5.14B | +210.42% | 0.00% |
| SEA | 22.87% | $1.36B | +27.44% | 0.00% |
| STEP | 22.78% | $4.75B | +155.56% | 1.33% |
| PAAS | 22.65% | $8.26B | +56.04% | 1.78% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| UFPI | <0.01% | $7.78B | +17.42% | 1.01% |
| NNVC | -<0.01% | $19.66M | +25.69% | 0.00% |
| API | 0.01% | $299.01M | +33.12% | 0.00% |
| HELE | 0.01% | $1.53B | -34.86% | 0.00% |
| JXN | -0.02% | $7.35B | +117.92% | 2.75% |
| VVI | -0.02% | $911.47M | +33.93% | 0.00% |
| PFGC | -0.02% | $12.91B | +33.83% | 0.00% |
| TFC | -0.02% | $61.90B | +47.66% | 4.44% |
| TCMD | 0.02% | $378.43M | +24.66% | 0.00% |
| SG | 0.04% | $4.38B | +299.68% | 0.00% |
| AB | 0.04% | $4.14B | +29.43% | 8.13% |
| AMN | 0.04% | $953.75M | -62.61% | 0.00% |
| HFWA | 0.04% | $873.99M | +47.58% | 3.58% |
| LNN | 0.05% | $1.35B | +3.22% | 1.14% |
| SIMO | -0.05% | $1.79B | -8.38% | 3.73% |
| TJX | -0.05% | $134.85B | +34.23% | 1.22% |
| VSAT | -0.06% | $876.93M | -65.78% | 0.00% |
| QGEN | -0.06% | $9.05B | -1.92% | 0.00% |
| HRZN | -0.06% | - | - | 14.26% |
| LTRN | -0.06% | $33.22M | -22.61% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| EPC | -18.93% | $1.69B | +0.38% | 1.74% |
| FLUT | -18.34% | $46.89B | +66.83% | 0.00% |
| CRVL | -18.31% | $6.14B | +68.42% | 0.00% |
| JKHY | -17.48% | $12.52B | +12.24% | 1.27% |
| MOMO | -17.47% | $909.44M | +4.43% | 0.00% |
| UEIC | -17.12% | $148.52M | +43.22% | 0.00% |
| PEP | -16.76% | $215.02B | -6.60% | 3.35% |
| CME | -16.74% | $82.76B | +9.21% | 1.98% |
| CELH | -16.55% | $6.41B | -47.81% | 0.00% |
| OFLX | -15.69% | $509.01M | -24.87% | 2.66% |
| CBOE | -15.64% | $21.46B | +15.84% | 1.11% |
| DKNG | -15.18% | $21.07B | +13.03% | 0.00% |
| AY | -14.35% | $2.57B | +16.60% | 8.05% |
| DNB | -14.00% | $5.29B | +20.54% | 1.69% |
| FIS | -13.64% | $46.34B | +59.70% | 1.86% |
| DLTH | -13.63% | $124.02M | -31.26% | 0.00% |
| NOC | -13.56% | $71.54B | +4.23% | 1.60% |
| TSN | -13.50% | $21.95B | +31.14% | 3.11% |
| SFM | -13.27% | $14.34B | +254.87% | 0.00% |
| ADP | -13.12% | $121.23B | +28.69% | 1.89% |
ETF's related to INSM
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| QQA | 47.09% | $135.01M | 0% |
| RSPA | 43.59% | $273.87M | 0% |
| EFAA | 27.84% | $117.38M | 0% |
| SLVP | 20.18% | $228.48M | 0.39% |
| SILJ | 17.40% | $945.80M | 0.69% |
| XBI | 17.21% | $6.58B | 0.35% |
| SIL | 16.61% | $1.22B | 0.65% |
| GDXJ | 16.10% | $5.06B | 0.52% |
| IPO | 16.05% | $157.08M | 0.6% |
| PRNT | 15.80% | $95.35M | 0.66% |
| CMDY | 15.65% | $279.14M | 0.28% |
| FTGC | 14.98% | $2.17B | 1.02% |
| PTH | 14.94% | $143.31M | 0.6% |
| XPH | 14.84% | $157.87M | 0.35% |
| GDX | 14.82% | $13.69B | 0.51% |
| FBCG | 14.73% | $2.55B | 0.59% |
| DBB | 14.60% | $126.37M | 0.77% |
| SFYF | 14.49% | $19.96M | 0.29% |
| XME | 14.47% | $1.86B | 0.35% |
| ARGT | 14.37% | $571.58M | 0.59% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BSCU | -<0.01% | $1.03B | 0.1% |
| BGRN | 0.01% | $389.17M | 0.2% |
| NUBD | 0.01% | $404.67M | 0.16% |
| JPMB | 0.03% | $585.28M | 0.39% |
| MNA | 0.05% | $220.85M | 0.77% |
| GLOV | 0.06% | $1.04B | 0.25% |
| SCHD | -0.07% | $65.70B | 0.06% |
| PCY | -0.07% | $1.33B | 0.5% |
| DIAL | 0.08% | $368.52M | 0.28% |
| IBTG | -0.09% | $1.48B | 0.07% |
| RSPH | -0.10% | $885.96M | 0.4% |
| FLTR | 0.10% | $1.79B | 0.14% |
| PFFR | 0.12% | $112.85M | 0.45% |
| CNBS | 0.12% | $21.10M | 0.77% |
| FLMI | 0.12% | $356.19M | 0.3% |
| VNLA | -0.13% | $2.27B | 0.23% |
| BSJO | -0.13% | $467.93M | 0.43% |
| IYH | 0.14% | $3.19B | 0.39% |
| VWOB | -0.14% | $5.40B | 0.2% |
| FXR | 0.15% | $2.08B | 0.61% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -15.93% | $388.04M | 1.43% |
| CCOR | -11.01% | $109.04M | 1.18% |
| IYK | -10.22% | $1.30B | 0.4% |
| EPHE | -9.19% | $99.70M | 0.59% |
| TBIL | -9.12% | $4.38B | 0.15% |
| IBTE | -8.68% | $1.70B | 0.07% |
| GOVZ | -8.52% | $313.00M | 0.1% |
| TLTW | -8.44% | $1.09B | 0.35% |
| FXG | -7.97% | $393.25M | 0.63% |
| EDV | -7.79% | $3.88B | 0.06% |
| UUP | -7.62% | $309.25M | 0.77% |
| SCHQ | -7.57% | $762.08M | 0.03% |
| ZROZ | -7.55% | $1.63B | 0.15% |
| USDU | -7.33% | $201.97M | 0.5% |
| SPTL | -6.91% | $10.33B | 0.03% |
| SHV | -6.90% | $18.13B | 0.15% |
| IGRO | -6.89% | $879.63M | 0.15% |
| SOYB | -6.85% | $27.32M | 0.22% |
| FTXG | -6.82% | $30.81M | 0.6% |
| LTPZ | -6.81% | $715.65M | 0.2% |
News
SeekingAlpha
Insmed sees growth with ARIKAYCE and upcoming Brensocatib approval. Find out why INSM stock is a strong pick with significant potential in the PAH market.
Yahoo
Sector Update: Health Care Stocks Decline
Yahoo
Sector Update: Health Care Stocks Mixed Tuesday Afternoon
Finnhub
BRIDGEWATER - Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases,...
Yahoo
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement awards to 27 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.
Yahoo
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences:
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.